As part of the diagnostic work-up of colon cancer, NCCN and ESMO recommend pathology review, tumour marker testing (carcinoembryonic antigen, CEA), colonoscopy, and CT chest-abdomen-pelvis. The gene discussed is CEACAM5; the disease is neoplasm.